Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination

Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination

Vaccination against SARS-CoV-2 is considered the most effective method of prevention to contain the pandemic. While highly effective SARS-CoV-2 vaccines are being applied on a large-scale, whether and to what extent the strength of the vaccine-induced immune response could be further potentiated is...

Full description

Bibliographic Details
Main Authors: Vincenzo Puro, Concetta Castilletti, Chiara Agrati, Delia Goletti, Sara Leone, Alessandro Agresta, Eleonora Cimini, Eleonora Tartaglia, Rita Casetti, Francesca Colavita, Silvia Meschi, Giulia Matusali, Daniele Lapa, Saeid Najafi Fard, Alessandra Aiello, Chiara Farrone, Paola Gallì, Maria Rosaria Capobianchi, Giuseppe Ippolito, on behalf of the INMI COVID-19 Vaccine Study Group
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Vaccines
Subjects:
influenza
pneumoccocus
COVID-19
SARS-CoV-2
vaccine
immune response
Online Access:https://www.mdpi.com/2076-393X/9/6/615

Internet

https://www.mdpi.com/2076-393X/9/6/615

Similar Items